Vaxart Common Stock vs Intangible Assets Analysis
| VXRT Stock | USD 1.02 0.08 8.51% |
Vaxart financial indicator trend analysis is much more than just breaking down Vaxart Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxart Inc is a good investment. Please check the relationship between Vaxart Common Stock and its Intangible Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Common Stock vs Intangible Assets
Common Stock vs Intangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaxart Inc Common Stock account and Intangible Assets. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Vaxart's Common Stock and Intangible Assets is -0.7. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Intangible Assets in the same time period over historical financial statements of Vaxart Inc, assuming nothing else is changed. The correlation between historical values of Vaxart's Common Stock and Intangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Vaxart Inc are associated (or correlated) with its Intangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Intangible Assets has no effect on the direction of Common Stock i.e., Vaxart's Common Stock and Intangible Assets go up and down completely randomly.
Correlation Coefficient | -0.7 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Common Stock
Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Most indicators from Vaxart's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxart Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. Enterprise Value is likely to gain to about 130.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 21.2 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 70.6M | 110.4M | 86.2M | 44.6M | Cost Of Revenue | 48.7M | 3.3M | 4.5M | 4.3M |
Vaxart fundamental ratios Correlations
Click cells to compare fundamentals
Vaxart Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxart fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 37.0M | 152.6M | 221.2M | 153.8M | 91.8M | 150.6M | |
| Short Long Term Debt Total | 2.3M | 7.2M | 13.0M | 21.7M | 26.5M | 28.4M | |
| Other Current Liab | 2.9M | 3.4M | 836K | 8.2M | 5.6M | 9.6M | |
| Total Current Liabilities | 9.2M | 11.8M | 10.8M | 17.9M | 13.7M | 17.6M | |
| Total Stockholder Equity | 13.0M | 123.4M | 187.5M | 110.6M | 57.8M | 89.3M | |
| Property Plant And Equipment Net | 2.2M | 8.3M | 19.8M | 41.3M | 36.6M | 27.5M | |
| Net Debt | (11.2M) | (119.7M) | (130.7M) | (22.3M) | (8.2M) | (8.7M) | |
| Retained Earnings | (116.7M) | (148.9M) | (219.4M) | (327.1M) | (409.6M) | (389.1M) | |
| Cash | 13.5M | 126.9M | 143.7M | 44.0M | 34.8M | 52.2M | |
| Non Current Assets Total | 19.4M | 24.1M | 52.0M | 54.4M | 46.3M | 40.4M | |
| Non Currrent Assets Other | 141K | 372K | 890K | 3.6M | 926K | 879.7K | |
| Cash And Short Term Investments | 13.5M | 126.9M | 166.5M | 93.7M | 39.7M | 61.2M | |
| Net Receivables | 3.6M | 334K | 71K | 20K | 3.0M | 2.9M | |
| Common Stock Shares Outstanding | 21.6M | 88.3M | 121.5M | 127.7M | 144.8M | 152.1M | |
| Liabilities And Stockholders Equity | 37.0M | 152.6M | 221.2M | 153.8M | 91.8M | 150.6M | |
| Non Current Liabilities Total | 14.9M | 17.4M | 22.9M | 25.3M | 20.3M | 27.5M | |
| Other Current Assets | 453K | 1.3M | 2.6M | 3.7M | 2.8M | 4.6M | |
| Other Stockholder Equity | 129.6M | 272.3M | 406.9M | 438.0M | 467.4M | 490.7M | |
| Total Liab | 24.1M | 29.2M | 33.6M | 43.3M | 34.0M | 44.6M | |
| Property Plant And Equipment Gross | 2.2M | 8.3M | 19.8M | 15.6M | 43.4M | 24.7M | |
| Total Current Assets | 17.6M | 128.5M | 169.2M | 99.5M | 45.5M | 43.3M | |
| Accumulated Other Comprehensive Income | (1.6M) | (459K) | (74K) | (299K) | (1K) | (1.1K) | |
| Short Term Debt | 841K | 2.1M | 1.0M | 2.2M | 6.5M | 6.8M | |
| Intangible Assets | 17.1M | 15.4M | 10.6M | 5.0M | 4.3M | 4.1M | |
| Accounts Payable | 852K | 2.1M | 3.9M | 5.5M | 1.6M | 1.5M | |
| Common Stock Total Equity | 714K | 4.8M | 11K | 13K | 11.7K | 11.1K | |
| Common Stock | 714K | 5K | 11K | 13K | 15K | 14.3K | |
| Current Deferred Revenue | 4.6M | 4.2M | 5.1M | 2M | 1.8M | 1.7M | |
| Other Liab | 13.4M | 14.9M | 10.9M | 5.9M | 6.7M | 7.9M | |
| Net Tangible Assets | 13.0M | 123.4M | 187.5M | 110.6M | 127.2M | 67.4M | |
| Other Assets | 141K | 372K | 890K | 3.6M | 4.1M | 4.3M | |
| Retained Earnings Total Equity | (116.7M) | (148.9M) | (219.4M) | (327.1M) | (294.4M) | (279.7M) | |
| Capital Surpluse | 124.8M | 272.3M | 406.9M | 438.0M | 503.7M | 528.9M | |
| Property Plant Equipment | 210K | 1.5M | 6.6M | 15.6M | 17.9M | 18.8M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaxart in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaxart's short interest history, or implied volatility extrapolated from Vaxart options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vaxart Inc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Vaxart Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vaxart Inc Stock. Highlighted below are key reports to facilitate an investment decision about Vaxart Inc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Vaxart Stock analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Vaxart's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxart. If investors know Vaxart will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxart listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 0.051 | Quarterly Revenue Growth 146.5 | Return On Assets (0.42) | Return On Equity (0.98) |
The market value of Vaxart Inc is measured differently than its book value, which is the value of Vaxart that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxart's value that differs from its market value or its book value, called intrinsic value, which is Vaxart's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxart's market value can be influenced by many factors that don't directly affect Vaxart's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxart's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxart is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxart's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.